Uma Prabhakar

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

Uma Prabhakar, Hiroshi Maeda, Rakesh K. Jain et al. · Cancer Research · 2013 · 1.4K citations

Nanoparticles, Workshop Discussions, Engineering +18

Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function

Manjula Reddy, Edward Eirikis, Cuc Davis et al. · Journal of Immunological Methods · 2004 · 288 citations

Inflammation, Cellular Immune Function, Autoimmune Disease +11

Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP™ assay

Uma Prabhakar, Edward Eirikis, Hugh M. Davis · Journal of Immunological Methods · 2002 · 184 citations

Inflammation, Cytokine, Labmap™ Assay +9

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

JF Rossi, Sylvie Négrier, Nicholas D. James et al. · British Journal of Cancer · 2010 · 184 citations · Full text

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Ewan Brown, Kellie A. Charles, Susan Hoare et al. · Annals of Oncology · 2008 · 180 citations · Full text

Advanced Cancer, Biological Effects, Medicine +10